President Trump credited Regeneron's experimental antibody cocktail for helping his recovery from COVID-19.. The treatment's early development process involved testing with cells derived from aborted fetal tissue, a practice the Trump administration strongly opposes. CBSN's Tanya Rivero spoke with CBS News reporter Kate Smith about how the cells were used and how the administration is responding.
